Immunovant, Inc. (IMVT) - Stock Prices, Stock Peers & Analysis

Home
IMVT

Company Name	Immunovant, Inc.
Symbol	IMVT
Currency	USD
Price	34.03
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	4,980,869,010
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	19.5 - 45.58
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Peter Salzmann M.B.A., M.D.
Website	https://immunovant.com

An error occurred while fetching data.

About Immunovant, Inc.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid